Vidarabine (Monohydrate)
Also known as: Ara-A
Vidarabine (Monohydrate) is adenosine analog. Vidarabine (Monohydrate) is antiviral agent. Vidarabine (Monohydrate) is active against herpes simplex viruses, varicella zoster virus and cytomegalovirus.
Primary Characteristics
Vidarabine (Monohydrate) is also known as Ara-A.
It is of Semi Synthetic origin and belongs to Arabinofuranosyladenine.
It belongs to DNA polymerase inhibitor pharmacological group on the basis of mechanism of action. It is also classified under Antiviral Agents .
Molecular Weight: 285.3 · Solubility in Water: 1 in 2000 · Non-proprietary name: Vidarabine (Monohydrate).

Pharmacokinetics
Elimination: plasma half-life is 3.3 hr, renal excretion is 1 - 3 % (unchanged)40-53%(metabolites).
Advertisement
Indications
Vidarabine (Monohydrate) is primarily indicated in conditions like Herpes simplex infections, Herpes simplex keratitis, Varicella zoster infections.
Contraindications
Vidarabine (Monohydrate) is contraindicated in conditions like Hypersensitivity to the drug.
Dosage
Vidarabine (Monohydrate)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1.041 mg/kg.hr | 1.041 mg/kg.hr | Every 24h | IV Inf | For 12 Hours in a Day |
| 3 % | 3 % | Every 4.8h | Ophthalmic | As Required |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Vidarabine (Monohydrate) in overdosage may give rise to further complications which include Megaloblastic anemia.
The signs and symptoms that are produced after acute overdosage of Vidarabine (Monohydrate) are Thrombocytopenia , Hematopoietic depression.
Vidarabine (Monohydrate) is known to cause more or less tolerable side effects which are usually transient. These include Anorexia , Ataxia, Confusion, Diarrhea, Dizziness, Hallucination , Nausea and vomiting, Phosis , Tremor.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.6.5.1 — Herpes and cytomegalovirus infection
- 2.21.1.2 — Antivirals